Font Size: a A A
Keyword [ANCA-Associated vasculitis]
Result: 41 - 60 | Page: 3 of 5
41. The Clinical Features And Prognosis Of ANCA Associated Interstitial Pneumonia
42. Clinical Pathological And Prognosis Analysis Of ANCA-associated Vasculitis With Renal Damage And Case Report Of Posterior Reversible Encephalopathy Syndrome With Literature Review
43. Analysis On The Histopathologic Classification, Clinical Characteristics And Outcome In Patients With ANCA-associated Glomerulonephritis
44. The Study On The Correlation Between Serum CD146 Level And Systemic Vasculitis
45. Investigation On The Risk Factors And The Mechanism Of Thromboembolic Events In ANCA Associated Vasculitis
46. Prognostic Factors In MPO-ANCA-associated Vasculitis With Renal Involvement
47. Retrospective Clinical And Pathological Analysis Of 101 ANCA- Associated Vasculitis Patients With Kidney Injury
48. Effect Of Plasma Exchange On Patients With ANCA Associated Vasculitis: A Meta-analysis
49. Clinical Analysis Of ANCA Associated Vasculitis Patients With Lung Involvement
50. The Real World Investigation Of ANCA And Clinical Analyze Of ANCA Associated Vasculitis
51. Clinical Characteristics And Prognosis Of ANCA-associated Vasculitis With Thrombocytopenia
52. A Study On The Changes And Significance Of MPO Synthesis,expression And Secretion Of Neutrophils In Patients With MPO-AAV
53. ANCA Associated Vasculitis With AKI:Clinical Analysis
54. Correlation Between Plasma MIF And The Disease Activity And Cardio-cerebrovascular Events In Patients With ANCA-Associated Vasculitis
55. The Role And Mechanism Of Soluble Urokinase Plasminogen Activator Receptor In ANCA-associated Vasculitis
56. The Regulatory Mechanism Of TIM-3 In ANCA Associated Vasculitis
57. Clinical And Genetic Studies Of Systemic Vasculitis
58. Pulmonary CT Findings And Related Clinical Analysis Of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
59. Preliminary Establishment Of MPO-ANCA Reference Interval And Analysis Of Clinical Disease Spectrum Of Positive Patients
60. Clinical Significance Of Differentially Expressed Plasma Exosomal Long Non-coding RNA （LncRNAs） In Patients With MPO-AAV
  <<First  <Prev  Next>  Last>>  Jump to